Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Bogotá, Colombia.
Horm Metab Res. 2010 Dec;42(13):977-81. doi: 10.1055/s-0030-1267175. Epub 2010 Oct 13.
A growing number of studies have demonstrated an association between serum levels of insulin-like growth factors (IGFs) and IGF binding protein-3 (IGFBP-3) and increased risk for various cancers. The aim of this study was to evaluate the relationship between levels of IGF-II or IGFBP-3 in cervical scrapes with cervical cancer and precancerous lesions: low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL). 4 groups of cases were examined: LSIL (n=20), HSIL (n=28), cervical cancer (n=45), and controls (n=51). Control subjects were women with normal, HPV DNA-negative Papanicolau (Pap) test. IGF-II and IGFBP-3 levels in cervical scrapes were measured by ELISA. Results show that median protein levels of IGF-II were significantly lower in cervical cancer cases vs. controls (446.5 ng/mg vs. 1,168.6 ng/mg, p<0.001). Significantly higher values of IGFBP-3 were found in HSIL vs. controls (median: 549.5 ng/mg vs. 216 ng/mg; p=0.018), and were not affected by HR HPV infection, meanwhile no significant differences were observed in IGFBP-3 levels between LSIL or cervical cancer as compared to controls. These data suggests that the progression to cervical cancer is associated with alterations in the IGF system and not affected by HR HPV infection. More studies are needed to understand the possible role of IGFBP-3 in cervical carcinogenesis.
越来越多的研究表明,血清胰岛素样生长因子(IGF)及其结合蛋白-3(IGFBP-3)水平与多种癌症的风险增加有关。本研究旨在评估宫颈刮片中 IGF-II 或 IGFBP-3 水平与宫颈癌及癌前病变(低级别鳞状上皮内病变[LSIL]和高级别鳞状上皮内病变[HSIL])之间的关系。共检查了 4 组病例:LSIL(n=20)、HSIL(n=28)、宫颈癌(n=45)和对照组(n=51)。对照组为 HPV DNA 阴性的巴氏涂片(Pap)检查正常的女性。采用 ELISA 法检测宫颈刮片中 IGF-II 和 IGFBP-3 水平。结果显示,宫颈癌组 IGF-II 蛋白水平中位数明显低于对照组(446.5ng/mg 比 1168.6ng/mg,p<0.001)。HSIL 组 IGFBP-3 值明显高于对照组(中位数:549.5ng/mg 比 216ng/mg;p=0.018),且不受 HR HPV 感染影响,而 LSIL 或宫颈癌与对照组相比,IGFBP-3 水平无显著差异。这些数据表明,宫颈癌的进展与 IGF 系统的改变有关,而不受 HR HPV 感染的影响。需要进一步研究以了解 IGFBP-3 在宫颈癌发生中的可能作用。